Randomized Controlled Trial of FTY720 Versus MMF in De Novo Renal Transplantation-Reference-Cited by-同舟云学术

Randomized Controlled Trial of FTY720 Versus MMF in De Novo Renal Transplantation

Published:2006-12-27 Issue:12 Volume:82 Page:1689-1697
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Tedesco-Silva Helio,Pescovitz Mark D.,Cibrik Diane,Rees Michael A.,Mulgaonkar Shamkant,Kahan Barry D.,Gugliuzza Kristene K.,Rajagopalan P. R.,Esmeraldo Ronaldo de M.,Lord Hélène,Salvadori Maurizio,Slade Jennifer M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference15 articles.

1. The immune modulator FTY720 targets sphingosine 1-phosphate receptors.;Brinkmann;J Biol Chem,2002

2. Alteration of lymphocyte trafficking by sphingosine 1-phosphate receptor agonists.;Mandala;Science,2002

3. FTY720: Targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity.;Brinkmann;Curr Opin Immunol,2002

4. Immunosuppressive drugs for kidney transplantation.;Halloran;N Engl J Med,2004

5. FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study.;Mulgaonkar;Am J Transplant,2006

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking sphingosine 1-phosphate receptor 1 with modulators reduces immune cells infiltration and alleviates endometriosis in mice;Reproductive BioMedicine Online;2023-11

2. Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis;Pharmacology & Therapeutics;2023-06

3. Effect of fingolimod therapy on quantitative macular changes among patients with relapsing-remitting multiple sclerosis: a four-year follow-up study from Oman;BMC Ophthalmology;2022-12-05

4. New immunosuppressive agents in transplantation;La Presse Médicale;2022-12